1. Home
  2. Startups
  3. Nexuspiral Inc.

Overview

Nexuspiral is developing ST genome editing technology using only oligonucleotides. Because this technology enables accurate genome editing, application to the treatment of human genetic diseases is expected. We have started research for the development of therapeutic agents for specific diseases. We are looking for research partners on specific diseases.
We are also looking for capital investors.

Technology
Accurate and precise genome editing technology using only oligonucleotides.
Establishment
2019
Location
Kobe, Hyogo, Japan
Industry
Biotech
Indication
Genome editing
Funding Round
Early
Raising
$227,000

Team

Get in touch with us:

Please tell us a little bit about yourself and why you'd like to get connected.
We will get back to you shortly.

Your Name
Your E-mail
Your Company
Your Role
Message